期刊文献+

二氢青蒿素对大鼠牛Ⅱ型胶原蛋白诱导关节炎模型作用的初步研究 被引量:5

Effects of Dihydroartemisinin on Collagen Ⅱ-induced Arthritis in Rats Model
原文传递
导出
摘要 目的建立牛Ⅱ型胶原蛋白(BCⅡ)诱导的大鼠关节炎(collagenⅡ-induced arthritis,CIA)动物模型,研究二氢青蒿素对大鼠关节炎的影响。方法选用雄性Wistar大鼠,在模型组(n=19)大鼠尾根及脊背部皮内注射用弗氏完全佐剂乳化的BCⅡ0.3mg,第15d以同样的剂量在同样的部位加强免疫1次;正常对照组(n=5)以生理盐水按同样的方法和剂量注射。第52d,将模型组分为单纯模型组(模型空白组,n=7)、二氢青蒿素组〔二氢青蒿素1.5mL/(kg.d),1mL含20mg二氢青蒿素,灌胃;n=12〕。治疗28d后观察大鼠的关节炎表现。结果模型组大鼠关节肿胀明显,而正常对照组关节无炎性红肿。二氢青蒿素组:关节肿胀减轻,组织病理检查见只有少量炎性细胞浸润,少量纤维结缔组织和毛细血管增生,关节腔较干净,没有明显的骨质破坏。治疗28d后,模型空白组关节炎指数较治疗前和正常对照组增加(P<0.05);二氢青蒿素组与治疗前比较差异无统计学意义(P>0.05),仍高于正常对照组(P<0.05)。治疗28d后,模型空白组病理分级高于正常对照组(P<0.05),二氢青蒿素组低于模型空白组(P<0.05)。结论初步实验表明二氢青蒿素有减轻Ⅱ型胶原诱导的大鼠关节炎病变作用。 Objective To study the effects of dihydroartemisinin on collagen-induced arthritis (CIA) in rats model. Methods CIA was induced in Male Wistar rats by intradermal injection of emulsion of 0. 3 mg type collagen in Freund's completead juvant (C Ⅱ/FA) at the base of the tail and repeated one times after 15 days. The normal control rats received the injection of the same volume of saline 52 days later, the CIA rats were divided into dihydroartemisinin treated group, saline treated group, in which the rats were subjected to the treatment of dihydroartemisinin 30 mg/(kg · d) or the same volume of saline for 28 days, then the effects of the treatments on arthritis were evaluated.. Results Compared with the normal rats, the joints of non-treated CIA rats were obviously swollen. After the treatment of dihydroartemisinin, the joints of CIA rats appeared less inflammation cell erosion, less proliferation of fibrous connective tissue and blood capillary, more clear, articular cavity and no bone erosion. Conclusion This preliminary study indicated dihydroartemisinin may have the effects to relieve CIA in rats.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期851-854,共4页 Journal of Sichuan University(Medical Sciences)
关键词 胶原性关节炎 Ⅱ型胶原 类风湿关节炎 二氢青蒿素 Collagen-induced arthritis Type Ⅱ collagen Rheumatoid arthritis Dihydroartemisinin
  • 相关文献

参考文献11

  • 1Bansbaek NJ, Regier DA, Ara R, et al. An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists. Drugs, 2005 ; 65(4) : 473-496.
  • 2Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? Ann Rheum Dis, 2004, 63 (10) :1186-1194.
  • 3Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med, 1977 ; 146(3) :857-868.
  • 4Wang JX, Tang W, Shi LP, et al. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation. Br J Pharmacol,2007;150(5) :652-661.
  • 5Sims NA, Green JR, Glatt M, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen- induced arthritis. Arthritis Rheum, 2004 ,50(7) :2338-2346.
  • 6Cuzzocrea S, McDonald MC, Mota-Filipe H, et al Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum, 2000 ;43(2) : 320-328.
  • 7Wang CR, Chen SY, Wu CL, et al. Prophylactic adenovirus mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum, 2005 , 52(4) : 1319-1324.
  • 8Takeshita M, Sugita T, Takata 1. Pathological evaluation of effect of anti-rheumatic drugs on type II collagen induced arthritis in Lewis rats. Exp Anita, 1997;46(2):165-169.
  • 9徐振海.青蒿素药物作用研究简介[J].安徽预防医学杂志,2004,10(3):181-182. 被引量:10
  • 10李菌,周慧君.二氢青蒿素抑制K562细胞血管内皮生长因子的表达[J].药学学报,2005,40(11):1041-1045. 被引量:28

二级参考文献2

共引文献36

同被引文献49

  • 1Tschauner C ,Ftirntrath F,Saba Y,et al. Developmental dysplasia of the hip: impact of sonographic newborn hip screening on the outcome of early treated decentered hip joints-a single center retrospective comparative cohort study based on Graf's method of hip uhrasonogra- phy [J]. J Child Orthop,2011,5(6) :415-424.
  • 2Semenowicz J, Szymafiski S, Walo R, et al. Total hip arthroplasty with shortening subtrochanteric Z osteotomy in the treatment of develop- mental dysplasia with high hip dislocation [J]. Ortop Traumatol Reha- bi1,2012,14(4) :341-349.
  • 3Yau CH,Choi KY,Kwong NS,et al. Frequency of developmental dysplasia of the hip in breech-presented Chinese neonates in Hong Kong [J]. Hong Kong Med J,2012,18(5):407-411.
  • 4Huang ./, Siragy H M. Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear tactor- kappaB,and activator protein - 1 signaling pathways [ J ] Endocri- nology,2010,151:3317 - 3325.
  • 5Eybl V,Kotyzov D,Cern P,et al. Effect of melatonin, curcumin quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe- NTA) -induced renal oxidative damage in rats [ J ]. Hum Exp Tox col ,2008,27:347 - 353.
  • 6Lisa LG, Alexandra CN. Spatiotemporal dynamics of lipid signaling protein kinase C as a paradigm [ J 1 IUBMB Life, 2008,60:782 - 789.
  • 7Noh H, King GL. The role of protein kinase C nephrnpathy[ J]. Kidney Int Suppl,2007,106 $49 - 53.
  • 8Lee WC, Chen HC,Wang CY,et al. Cilostazol ameliorates nephrop- athy in type 1 diabetic rats involving improvement in oxidative stress and regulation of tgf - Beta and NF - kappaB[ J]. Biosci Biotechnol Biochem ,2010,74(7 ) : 1355 - 1361.
  • 9Liang YJ,Jian JH,Liu YC,et al. Advanced glycation end products- induced apoptosis attenuated by PPARdelta activation and epigallo- catechin gallate through NF- kappaB pathway in human embryonic kidney cells and human mesangial ceils [ J ]. Diabetes Metab Res Rev,2010,26(5) :406 -416.
  • 10Matsui T, Yamagishi S,Takeuchi M. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) inter- action-mediated proximal tubular cell injury via peroxisome prolifer- ator-aetivated receptor-gamma activation[ J]. Biochem Biophys Res Commun,2010,398 (2) :326 - 330.

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部